Esophageal Varices Clinical Trial
Official title:
Difference in Aerosol-generating Amount Between Wired Magnetic-assisted Capsule Endoscopy System and Esophagogastroduodenoscopy Examination of Varices in Biliary Atresia Patients
The goal of this clinical trial is to compare the safeness and effectiveness of traditional esophagogastroduodenoscope (EGD) and wired magnetically assisted capsule endoscopy (MACE) in the diagnosis of esophageal varices in biliary atresia (BA) patients. The main questions it aims to answer are: - Subjects who do wired magnetically assisted capsule endoscopy do not need to open the mouths during the process, this study also want to know whether wired magnetically assisted capsule endoscopy can reduce the generation of droplets. - Diagnostic accuracy between traditional esophagogastroduodenoscope and wired magnetically assisted capsule endoscopy in biliary atresia patients with esophageal varices. Participants will do either traditional esophagogastroduodenoscope or wired magnetically assisted capsule endoscopy.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years and older |
Eligibility | Inclusion Criteria: - Biliary atresia patients > 6 years old - Vital signs are stable - Without acute gastrointestinal bleeding Exclusion Criteria: - Patients with metal implants, metal stent, artificial joints, bone plates, and bone screw - Patients with electronic devices, such as pacemakers, cochlear implants, or other implanted electronic medical devices - Throat or esophageal obstruction leading to dysphagia patients - Consciousness disturbance patients unable to swallow - Patients with acute upper gastrointestinal bleeding - Patients with platelet lower than 40K or PT INR > 1.5 |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Taipei City |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital | Insight Medical Solutions |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Aerosol-generating amount | 1-2 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Recruiting |
NCT03989973 -
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
|
||
Completed |
NCT05485714 -
Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
|
||
Completed |
NCT01851252 -
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
|
Phase 1 | |
Completed |
NCT01360515 -
A Study of Disposable Transnasal Esophagoscope
|
N/A | |
Recruiting |
NCT04602663 -
Optimal Time for Follow up After Variceal Band Ligation
|
N/A | |
Recruiting |
NCT04499898 -
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
|
Phase 2/Phase 3 | |
Completed |
NCT00331188 -
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
|
Phase 3 | |
Enrolling by invitation |
NCT02767206 -
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.
|
N/A | |
Enrolling by invitation |
NCT05781828 -
Noninvasive Methods For Prediction of Esophageal Varices in Children
|
||
Not yet recruiting |
NCT05199038 -
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
|
Phase 4 | |
Recruiting |
NCT02740166 -
Preventing Recurrent Bleeding After Eradication of Esophageal Varices
|
Phase 4 | |
Completed |
NCT01893541 -
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?
|
Phase 4 | |
Terminated |
NCT00485290 -
Effect of Meal on Portal and Esophagus Variceal Pressure
|
N/A | |
Completed |
NCT01079416 -
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
|
N/A | |
Completed |
NCT01188733 -
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04254822 -
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
|
N/A | |
Recruiting |
NCT03212872 -
Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding
|
N/A | |
Completed |
NCT03748563 -
Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis
|
N/A | |
Completed |
NCT01059396 -
Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
|
Phase 4 |